arrow
M

Masao Honda

Kanazawa University
H指数:64
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chromatin Accessibility-Guided Targeting Identifies Structurally Constrained Regions in HBV cccDNA and Suppresses Viral Replication

染色质可及性指导靶向识别HBV cccDNA中的结构限制区域并抑制病毒复制

2026-08-040
OA
Correction: Ishida et al. Wnt/β-Catenin Signaling Regulates Hepatitis B Virus cccDNA Levels. Int. J. Mol. Sci. 2025, 26, 6942

更正:Ishida等人 Wnt/β-连环蛋白信号通路调节乙型肝炎病毒共价闭合环状DNA水平。Int. J. Mol. Sci. 2025, 26, 6942

2026-05-300
OA
Netrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infection

Netrin-1抑制乙型肝炎病毒对肝细胞的附着和内化感染

2025-12-170
PRE
Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A Antibodies

血管内皮生长因子受体2靶向治疗抑制了联合程序性死亡配体1抗体和血管内皮生长因子A抗体治疗后,甲胎蛋白阳性肝细胞癌的进展。

2025-10-010
OAAI
The SELENOP Polymorphism rs7579 Predicts Hepatic Steatosis in Females With Insulin Resistance in the General Population

SELENOP多态性rs7579可预测普通人群中胰岛素抵抗女性的肝脂肪变性。

2025-10-010
OAAI
Human Leukocyte Antigen Genotypes Affect Hepatitis B Virus Mutations Associated With Hepatocellular Carcinoma

人类白细胞抗原基因型影响与肝细胞癌相关的乙型肝炎病毒突变

2025-07-290
PRE
Transcription factor JUNB is required for transformation of EpCAM-positive hepatocellular carcinoma (HCC) cells into CD90-positive HCC cells in vitro

转录因子JUNB对于在体外将EpCAM阳性的肝细胞癌(HCC)细胞转化为CD90阳性的HCC细胞是必需的。

2025-04-190
OA
The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinoma

顺铂加肝动脉灌注化疗联合来伐替尼治疗晚期肝癌的疗效和安全性

2025-04-010
PRE
High-Throughput Screening of Antiviral Compounds Using a Recombinant Hepatitis B Virus and Identification of a Possible Infection Inhibitor, Skimmianine
2024-08-221
OAAI
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence

血清MYCN作为预测预后和治疗反应的生物标志物在预防肝细胞癌复发中的作用

2024-02-212
OA